CH20 CH20 CH20 | Premium Research-Grade Beauty Peptide |Chonluten| 99% Purity | Lyophilized Powder | High Quality | Retatrutide, Tirzepatide
TDS 1 Inquiries
75007-24-8
Pharmaceutical Grade
99%
Hong Kong
customizable
10vials/box
2027-12-31
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceGlu-Asp-Gly is an oligopeptide.Certificates
-
TDS
Basic Info-
Product Name:
(4S)-4-amino-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Other Name:Glu-Asp-Gly;glutamyl-aspartyl-glycine;H-Glu-Asp-Gly-OH;T-34 tripeptide;Glu-asp-gly;Glutamyl-aspartyl-glycine;75007-24-8;(4S)-4-amino-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;H-Glu-asp-gly-OH;T-34 tripeptide;L-Glutamyl-L-aspartyl-glycine;SCHEMBL3909775;DTXSID80996513;CHEBI:162780;Glycine, N-(N-L-alpha-glutamyl-L-alpha-aspartyl)-;4-Amino-5-({3-carboxy-1-[(carboxymethyl)imino]-1-hydroxypropan-2-yl}imino)-5-hydroxypentanoic acid
CAS No.:75007-24-8
Molecular Formula:C11H17N3O8
InChIKeys:DSPQRJXOIXHOHK-WDSKDSINSA-N
Molecular Weight:319.27 g/mol
Exact Mass:319.10156451 g/mol
Categories:
Characteristics-
PSA:
196 Ų
XLogP3:-1.1791
Melting Point:143 - 145 °C
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Location:
Building 1, Floor 2, No. 96 Banhe Road, Huangpu District, Guangzhou City, Room 2164
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
12
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA
"> -
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
United Kingdom
Chonluten
10 PCS Apr 15, 2026 Post an enquiry for this product
Company Profile of Guangzhou Henghuang Trading Co., Ltd. 